≥ 60 year-old | Univariate | Multivariate | ||
---|---|---|---|---|
HR (95% CI) | p | HR (95% CI) | p | |
Sex, female | 1.548 (1.119–2.142) | 0.008 | 1.398 (1.199–1.631) | <  0.001 |
BMI (kg/m2) | 0.991 (0.939–1.046) | 0.741 |  |  |
Cause of ESRD | ||||
 Diabetes mellitus | 1 |  |  |  |
 Hypertension | 0.898 (0.554–1.454) | 0.661 |  |  |
 Glomerulonephritis | 1.192 (0.767–1.854) | 0.436 |  |  |
 ADPKD | 0.781 (0.334–1.823) | 0.568 |  |  |
 Others | 1.135 (0.452–2.850) | 0.787 |  |  |
 Unknown | 1.226 (0.778–1.932) | 0.379 |  |  |
Duration of dialysis (month) | 1.003 (1.001–1.005) | 0.004 | 1.001 (1.000–1.002) | 0.156 |
Diabetes mellitus | 0.880 (0.635–1.219) | 0.441 |  |  |
Hypertension | 0.663 (0.375–1.172) | 0.157 |  |  |
Cardiovascular disease | 0.931 (0.627–1.384) | 0.725 |  |  |
Creatinine, baseline (mg/dL) | 0.988 (0.935–1.045) | 0.680 |  |  |
Creatinine, discharge (mg/dL) | 1.153 (0.945–1.408) | 0.161 |  |  |
Re-transplantation | 0.994 (0.520–1.901) | 0.986 |  |  |
Deceased donor | 1.495 (1.076–2.077) | 0.017 | 1.364 (1.137–1.637) | 0.001 |
Donor age (year) | 1.022 (1.009–1.034) | 0.001 | 1.010 (1.004–1.016) | 0.001 |
Donor sex, female | 1.204 (0.864–1.677) | 0.273 |  |  |
Desensitization | 1.257 (0.849–1.859) | 0.253 |  |  |
ABO incompatibility | 1.050 (0.662–1.667) | 0.836 |  |  |
Presence of DSA | 1.324 (0.749–2.340) | 0.334 |  |  |
Length of hospitalization after KT (day) | 1.016 (1.008–1.025) | <  0.001 | 1.010 (1.006–1.014) | <  0.001 |
Induction immunosuppression | ||||
No use | 1 | Â | 1 | Â |
 Basiliximab | 1.513 (0.373–6.134) | 0.562 | 2.051 (0.916–4.593) | 0.081 |
 ATG | 2.022 (0.489–8.357) | 0.331 | 2.131 (0.941–4.827) | 0.070 |
 Basiliximab + ATG | 5.087 (0.987–26.223) | 0.052 | 2.138 (0.851–5.370) | 0.106 |
Calcineurin inhibitors | ||||
 No use | 1 |  |  |  |
 Tacrolimus | 3.285 (0.460–23.478) | 0.236 |  |  |
 Cyclosporine | 0.495 (0.031–7.913) | 0.619 |  |  |
Steroid | 0.974 (0.361–2.631) | 0.958 |  |  |
Acute rejection | 3.377 (2.399–4.754) |  | 2.907 (2.471–3.419) | <  0.001 |